Skip to main content
. Author manuscript; available in PMC: 2017 Oct 1.
Published in final edited form as: Neurogastroenterol Motil. 2016 May 5;28(10):1508–1517. doi: 10.1111/nmo.12848

Table 1.

Demographics and GI, psychological, and quality of life measures

IBS (n=272) Non-FGID (n=246) p-value
Demographics
    Age (yrs) 47.6 ±0.9 51.6 ± 1.0 0.003
    Female sex (%) 221 (81) 161 (65) <0.001
GI Symptoms
    Bowel symptom bother (VAS) 6.9 ± 0.2 4.1 ± 0.2 <0.001
    Bowel symptom severity (VAS) 6.9 ± 0.2 4.0 ± 0.2 <0.001
    Bowel symptom frequency (days/last 2 wk) 9.0 ± 0.3 5.2 ± 0.4 <0.001
        GSRS-IBS
        Pain subscale 7.8 ± 0.2 4.5 ±0.2 <0.001
        Bloating subscale 10.3 ±0.3 6.4 ± 0.3 <0.001
        Constipation subscale 5.7 ±0.2 3.6 ±0.2 <0.001
        Diarrhea subscale 12.6 ±0.4 8.2 ±0.4 <0.001
Psychological measures (continuous)
    Beck depression inventory [BDI] 12.3 ± 0.6 7.8 ± 0.5 <0.001
    Beck anxiety inventory [BAI] 13.2 ±0.6 8.1 ±0.6 <0.001
    Patient-Health Questionnaire-15 [PHQ-15] 13.0 ± 0.3 9.4 ± 0.5 <0.001
    Patient-Health Questionnaire-12 [PHQ-12]* 8.5 ± 0.3 6.7 ± 0.4 <0.001
Psychological measures (dichotomous)
    Depression [BDI ≥20] (%) 59 (22) 26 (11) 0.001
    Anxiety [BAI ≥16] (%) 85 (31) 34 (14) <0.001
    Somatic Symptoms [PHQ-15 ≥15] (%) 82 (30) 30 (12) <0.001
Quality of life measures
    SF-36 Total 50.4 ± 1.4 63.8 ± 1.6 <0.001
        SF-36 Physical 44.5 ± 1.4 58.9 ± 1.7 <0.001
        SF-36 Mental 51.8 ± 1.5 63.5 ± 1.6 <0.001
*

PHQ-12(26) questionnaire excludes three GI symptoms (“stomach pain,” “constipation, loose bowels, or diarrhea,” and “nausea, gas, or indigestion”) from the PHQ-15.